Ilsung Is Co., Ltd. (KRX:003120)

South Korea flag South Korea · Delayed Price · Currency is KRW
23,100
-150 (-0.65%)
Apr 29, 2026, 3:30 PM KST
46.02%
Market Cap 160.98B
Revenue (ttm) 64.29B
Net Income (ttm) 1.17B
Shares Out 6.97M
EPS (ttm) n/a
PE Ratio 138.08
Forward PE n/a
Dividend 1,200.00 (5.20%)
Ex-Dividend Date Dec 29, 2025
Volume 4,358
Average Volume 3,246
Open 23,150
Previous Close 23,250
Day's Range 22,800 - 23,450
52-Week Range 15,640 - 31,450
Beta -0.12
RSI 48.84
Earnings Date Feb 26, 2026

About Ilsung Is

Ilsung Is Co., Ltd. operates as a pharmaceutical company in South Korea. Its products include antibiotics, analgesics, muscle relaxants, antipyretic-analgesics, antihistamine, neuropsychiatric, neuromuscular blocker/ central muscle relaxants, anti-coagulants, probiotics, vaccine, medical equipment, circulatory system drugs, contrast agents, muscle relaxants, diabetes treatments, osteopathic, digestive system medicines, anti-virals, anti-emetics, respiratory treatments, adrenal cortical steroids, anesthetics, antipyretics, and cardiovascular sys... [Read more]

Sector Healthcare
Founded 1954
Country South Korea
Stock Exchange Korea Stock Exchange
Ticker Symbol 003120
Full Company Profile

Financial Performance

In 2025, Ilsung Is's revenue was 64.29 billion, a decrease of -6.85% compared to the previous year's 69.02 billion. Earnings were 1.17 billion, a decrease of -91.10%.

Financial Statements

News

There is no news available yet.